Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Manufacture Vaccines

Total Eradication

CPI – a member of the UK government's High Value Manufacturing Catapult – is collaborating with the University of Leeds, UK, to develop a low-cost, scalable manufacturing process for a non-infectious, stable vaccine against polio. Developed using virus-like particles (VLP), the vaccine is intended to improve the safety and accessibility of treatment, particularly in low- and middle-income countries.

Since the introduction of the Global Polio Eradication Initiative in 1988, cases of polio have plummeted by 99 percent – with the oral polio vaccine (OPV) playing a key role in facilitating large-scale immunization. But despite success with OPV, it suffers a number of drawbacks; firstly, the RNA-dependent RNA polymerase enzyme that is responsible for making copies of the PV genomic RNA is error-prone. “In rare cases, use of the OPV can, therefore, cause disease in vaccine recipients or their close contacts. In situations of low vaccine coverage, this can lead to localized outbreaks,” says Natasha Lethbridge, Project Manager, CPI.

Read the full article now

Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

About the Author

Maryam Mahdi

Associate Editor

After finishing my degree, I envisioned a career in science communications. However, life took an unexpected turn and I ended up teaching abroad. Though the experience was amazing and I learned a great deal from it, I jumped at the opportunity to work for Texere. I'm excited to see where this new journey takes me!

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register